24-Oct-2016 - ATCC has signed a strategic agreement with the contract research organization (CRO) BioAgilytix as part of its ongoing initiative to provide CRO services.
19-Oct-2016 - Almac Group’s Diagnostics business will engage with pharma to validate the link between its immune response assay and checkpoint inhibitor based therapy.
18-Oct-2016 - Lovelace Biomedical launched this week as a not-for-profit preclinical contract research organization (CRO) with a business model that will let it “put science first.”
18-Oct-2016 - Metrion has invested in new laboratories, equipment, and staff, as part of the companies continued growth strategy to form strategic alliances and add "additional breadth."
18-Oct-2016 - The U.S. Food and Drug Administration (FDA) has awarded 21 new clinical trial research grants totaling more than $23m over the next four years.
17-Oct-2016 - Thermo Fisher Scientific has revealed a preemptive pharmacogenomic risk factor screening tool to help increase drug development outcome efficiency and reduce adverse drug reactions.
17-Oct-2016 - Certara has expanded its operations as the company prepares to “fully leverage” the value of modeling and simulation in drug development.
13-Oct-2016 - Crown Bioscience has published a new version of its MuBase, its online database of efficacy/PD and humanized models, now including syngeneics, GEMM, chimeric, and allograft cancer models.
12-Oct-2016 - In a year of “merger mania,” researchers suggest the elimination of competition is reducing innovation in the pharmaceutical industry.
11-Oct-2016 - Charles River Laboratories has extended its integrated drug discovery alliance with Genentech for three additional years.
05-Oct-2016 - Sekisui XenoTech now offers hepatic human lysosomes and rat tritosomes as standard test systems for in vitro drug development.
03-Oct-2016 - As part of the company’s continued growth, Charles River’s recent partnership with The Tri-Institutional Therapeutics Discovery Institute (Tri-I TDI) will work to accelerate drug development.
03-Oct-2016 - With several systems and process improvement initiatives underway, the growing contract research organization (CRO), Venn Life Sciences, continues to look for earnings enhancing opportunities, says CEO.
29-Sep-2016 - QPS Holdings LLC and G-CURE BV will collaborate on cardiovascular drug development programs for pharmaceutical companies.
29-Sep-2016 - Charles River Laboratories has acquired Worcester, MA-based contract research organization (CRO) Agilux Laboratories, further bolstering the company’s early-stage services.
27-Sep-2016 - Pharmaron has acquired MSD’s Hoddesdon, UK-based Good Manufacturing Practice (GMP) standard facilities to advance its API and formulation development.
27-Sep-2016 - The latest in a series of investments, Alcami has strengthened its analytical services capabilities at its Edison, New Jersey-based site.
22-Sep-2016 - Crown Bioscience has published an updated version of its XenoBase, an online database collating cell line and cell line derived xenograft model data.
20-Sep-2016 - The collaboration combines Plasticell’s cell culture media for creating fat and bone cells in 2-dimensional cell cultures, with CellSpring’s high throughput 3-dimensional screening assays for drug discovery.
19-Sep-2016 - Through its acquisition of d3 Medicine, Certara has expanded its Strategic Consulting (CSC) division, which uses a range of methods to support drug development.
15-Sep-2016 - Fulcrum Therapeutics will use a CRISPR gene editing-based platform to identify genetic targets under a deal with Horizon Discovery Group.
06-Sep-2016 - More than two months after Britain decided to leave the EU, companies reevaluate the state of business and what comes next, specifically for jobs within the industry.
02-Sep-2016 - As stem cell and gene editing technologies become more advanced, researchers are increasingly interested in growing human tissues and organs in animals – but what are the implications of human-animal chimeras?
29-Aug-2016 - ACD/Labs’ flagship product ACD/ChemSketch allows pharmaceutical scientists to “better understand the fate of molecules,” says the company president.
25-Aug-2016 - Metrion Biosciences (Metrion), an ion-channel and drug discovery CRO, has joined a network of partners to evaluate the use of primary human dorsal root ganglion (hDRG) neurons in pain research.